134 related articles for article (PubMed ID: 38446476)
21. [Richter Syndrome: Diagnostic and Therapeutic Management].
Croizier C; Guièze R
Bull Cancer; 2021 May; 108(5):521-527. PubMed ID: 33896586
[TBL] [Abstract][Full Text] [Related]
22. Novel Richter Syndrome Xenograft Models to Study Genetic Architecture, Biology, and Therapy Responses.
Vaisitti T; Braggio E; Allan JN; Arruga F; Serra S; Zamò A; Tam W; Chadburn A; Furman RR; Deaglio S
Cancer Res; 2018 Jul; 78(13):3413-3420. PubMed ID: 29735551
[TBL] [Abstract][Full Text] [Related]
23. Epcoritamab is active in large B cell lymphomas.
Romero D
Nat Rev Clin Oncol; 2023 Mar; 20(3):138. PubMed ID: 36646813
[No Abstract] [Full Text] [Related]
24. Prognostication in Richter syndrome: context is everything.
Eyre TA
Br J Haematol; 2020 Sep; 190(6):811-812. PubMed ID: 32420622
[No Abstract] [Full Text] [Related]
25. Use of PD-1 (PDCD1) inhibitors for the treatment of Richter syndrome: experience at a single academic centre.
Rogers KA; Huang Y; Dotson E; Lundberg J; Andritsos LA; Awan FT; Woyach JA; Byrd JC
Br J Haematol; 2019 Apr; 185(2):363-366. PubMed ID: 30028000
[No Abstract] [Full Text] [Related]
26. The Ongoing Unmet Needs in Chronic Lymphocytic Leukemia: TP53 Disruption, Richter, and Beyond.
Ding W
Hematol Oncol Clin North Am; 2021 Aug; 35(4):739-759. PubMed ID: 34174984
[TBL] [Abstract][Full Text] [Related]
27. Richter Transformation Arising From Chronic Lymphocytic Leukemia.
Barnes Rogers B
Clin J Oncol Nurs; 2022 Feb; 26(1):14-17. PubMed ID: 35073287
[TBL] [Abstract][Full Text] [Related]
28. Sentinel case of Richter transformation from chronic lymphocytic leukaemia/small lymphocytic lymphoma to CD3+ diffuse large B-cell lymphoma.
Ismail A; Mallick JA; Qin D; Hussaini MO
J Clin Pathol; 2017 Jul; 70(7):575-578. PubMed ID: 27899414
[TBL] [Abstract][Full Text] [Related]
29. Accelerated Chronic Lymphocytic Leukemia and Richter Transformation in the Era of Novel Agents.
Levy Yurkovski I; Tadmor T
Acta Haematol; 2024; 147(1):73-83. PubMed ID: 37666234
[TBL] [Abstract][Full Text] [Related]
30. Bilateral acute orbital compartment syndrome secondary to Richter syndrome: the 'tulip' sign.
Stewart CM; McDonald B; Clifford R; Norris JH
Clin Exp Ophthalmol; 2016 Nov; 44(8):722-724. PubMed ID: 27061968
[No Abstract] [Full Text] [Related]
31. Richter transformation of chronic lymphocytic leukemia into composite diffuse large B-cell and Hodgkin lymphoma.
Michelis FV; Kourti G; Skertsou M; Karmiris T; Rontogianni DP; Harhalakis N
Leuk Lymphoma; 2012 Nov; 53(11):2302-3. PubMed ID: 22432520
[No Abstract] [Full Text] [Related]
32. Chimeric antigen receptor T-cell immunotherapy tackles blood cancers.
Brower V
J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25838441
[No Abstract] [Full Text] [Related]
33. Spontaneous tumor lysis syndrome in a patient with diffuse large B cell lymphoma and Richter syndrome.
Tufan A; Unal N; Koca E; Onal I; Aksu S; Haznedaroglu I
Ann Hematol; 2006 Mar; 85(3):183-4. PubMed ID: 16311735
[No Abstract] [Full Text] [Related]
34. Concurrent herpes simplex viral lymphadenitis and chronic lymphocytic leukemia/small lymphocytic lymphoma, mimicking large-cell (Richter) transformation.
Oo K; Xiao W; Hameed A; Xiao P
Leuk Lymphoma; 2009 Sep; 50(9):1535-7. PubMed ID: 19562615
[No Abstract] [Full Text] [Related]
35. Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell-Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II Trial.
Thieblemont C; Phillips T; Ghesquieres H; Cheah CY; Clausen MR; Cunningham D; Do YR; Feldman T; Gasiorowski R; Jurczak W; Kim TM; Lewis DJ; van der Poel M; Poon ML; Cota Stirner M; Kilavuz N; Chiu C; Chen M; Sacchi M; Elliott B; Ahmadi T; Hutchings M; Lugtenburg PJ
J Clin Oncol; 2023 Apr; 41(12):2238-2247. PubMed ID: 36548927
[TBL] [Abstract][Full Text] [Related]
36. Semimechanistic Physiologically-Based Pharmacokinetic/Pharmacodynamic Model Informing Epcoritamab Dose Selection for Patients With B-Cell Lymphomas.
Li T; Hiemstra IH; Chiu C; Oliveri RS; Elliott B; DeMarco D; Salcedo T; Egerod FL; Sasser K; Ahmadi T; Gupta M
Clin Pharmacol Ther; 2022 Nov; 112(5):1108-1119. PubMed ID: 35996883
[TBL] [Abstract][Full Text] [Related]
37. Richter transformation of chronic lymphocytic leukemia presenting as otitis externa.
Pilalas D; Daios S; Fotiadou A; Markou KD; Savopoulos C; Kaiafa G
Pol Arch Intern Med; 2021 May; 131(5):469-470. PubMed ID: 33769000
[No Abstract] [Full Text] [Related]
38. Plasmablastic Richter transformation as a resistance mechanism for chronic lymphocytic leukaemia treated with BCR signalling inhibitors.
Chan KL; Blombery P; Jones K; Lade S; Carney D; Tran H; Seymour JF; Tam CS
Br J Haematol; 2017 Apr; 177(2):324-328. PubMed ID: 27196127
[No Abstract] [Full Text] [Related]
39. Early Clones Expand in Richter Transformation of Chronic Lymphocytic Leukemia.
Cancer Discov; 2022 Oct; 12(10):OF8. PubMed ID: 35984230
[TBL] [Abstract][Full Text] [Related]
40. Morphologic and molecular analysis of Richter syndrome in chronic lymphocytic leukaemia patients treated with ibrutinib or venetoclax.
Gángó A; Kiss R; Farkas P; Hanna E; Demeter J; Deák B; Lévai D; Kotmayer L; Alpár D; Matolcsy A; Bödör C; Mátrai Z; Timár B
Pathology; 2022 Feb; 54(1):95-103. PubMed ID: 34332791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
